joining quarter Thank today. I you. Good us to today, had after market hope our results look issued you've and a We closed afternoon, them. and chance the thank you at for third
safety taken First important our of employees, safe we we hope the during has work the operations, continue healthy unprecedented employees while since measures are so We've to foremost full the safeguard of utmost advance maintaining COVID-XX, and important. time. been emergence doing. can to and this everyone of our we
First, let me provide context. some with you
clinical to in With At and the novel marketplace, New in with supply challenges onset many in the We cornovirus issues majority the including with third activities required States presented we same others our related Farmingdale, have to challenges needed of imagine, pandemic, the the critical to maintaining frontlines a perseverance, opportunities, the equipment, with on can the the we swabs, testing nearby bulk production consistent secure market. challenge York. our experienced quarter City, reagents. we principle United employees our the many and our epicenter the New quickly of personal serve are hurdles. protective headquarters of at capabilities you our company and with of needs staff, and as laboratory our As our supply in time tubes York overcome global of the
we were we to remote the at staff While authorities our as imposed standards, dedicated to work of for public. motivated home short was general show safety stay many to saying to we’re working even workers, transitioned to ill the and as and were search staffed We do up employees essential of some periods time. when our overcame capable unable employees environment, issues work
approaches did novel been occasion have Our rose needed and able our unrelenting to testing testing to their expand experiencing without an development COVID-XX to staff any interruptions. of efforts to job. Thanks the operating, continue we extraordinary
and to clinical stay Our hampered this business lab a country with positive by were entire cancelled. see offices it impacted all we company, this health closed determinantly as diagnostics be pleased and we laboratories they doctor's key on that to emerging virtually ordered home, companies, were forward science especially was and health nearly structure Patients Enzo moving and alike. pushed whether elements five are I'm from report networks at pandemic. was were in shutdown. elective environment the healthcare This March, procedures of
was the diagnostics there found at laboratories clinical large. appreciation and for new industry First, a
rapidly allowed us integration invested and to justified, vertical our and address over is model past testing in business Second, challenge. years nationwide and the open three the opportunistic platform
of points are go antibody for now volume. we demand. of bit a meeting Fourth, diagnostic Third, large. was challenges light clinical industry, to to multifaceted of address This testing. to vast further And we testing. both new has pandemic restructuring laboratories industry molecular the misperceptions needed capacity the we a diagnostic changing scaling in of fifth, novel launched diagnostic shed There at these on an this appreciation Allowing environment, a and rapidly rapidly found increase depth. are platform extensive the and turbulent the for through COVID-XX and in each fast
as diagnostics Over two hurt the restore back vitality past dramatically in has reduced and to critically years, being widely understood is were being value able the fundamental reimbursements and country. to better that now diagnostics was necessary come and Today, of a nation. being marginalized appreciated, proposition the to and sector point our to seen and this people
over to invested shed rapidly issues have is this effectively light three survive. and and company's our integration to address and vertical in justified Second, open business vertical years testing justified platform that developed to opportunistic integration navigate and past our proprietary challenge. supply and environment the us model allowed Crucial
our systems. For own our the we most chain part, own are using supply and
Women's adapted technological on effectively been for from We angles. utilize and building pre-COVID current COVID-XX our Health have and are swabs, our of GenFlex has capabilities several platform, development in We launched applying multiple that years with the address which own COVID-XX our to pandemic testing. been Panel, was reagents, manufacture of own the them
products these are customers, own clinical running and platforms using the and labs to tests selling well our We kits and systems laboratory. in as other as unique our
launched for have antibody testing. both an multifaceted extensive platform we molecular COVID-XX novel Third, and
the proprietary serological antibodies. own to offering virus, molecular for COVID-XX novel are as test our diagnostic internally detect coronavirus test well developed as the diagnostic a We
now early working drug of also are repurposing on treatment a for in COVID-XX. candidate the testing We
now scaling molecular basis. including on a capacity full instrumentation global as Enzo antibody, We a increase as COVID-XX well offering collection, products, to are of and rapidly Lifesciences volume. is sample range
from tests. antibody need week, COVID-XX supply than approximately testing initial increasing suppliers. of ramping stronger of Our ELISA other well commercial Labs manufacturing Clinical the weekly tests as our thousands and is margins molecular of Enzo test tests, security capacity XX,XXX a from to provides XX,XXX perform currently volume address capability internal as available to serological
demand. the meeting are we Finally,
this for entities of research RFP marketing York homes. bid state contract an additional with as project. is recent to a once to it XX,XXX states the This demand. academic more states District average New with to XX,XXX using XXX,XXX is for week that point, New government quite from this really The few by in let we David COVID been many estimated the Global meet support with want for analysis found. working even On during been provide more continued territory, to have over much ranging day, over than based recent the thank build I'm institutions of in analysis entities. considering months. fully turn There of our over to on laboratories demand call be of Health if research for U.S. the successful investment will to of The states with Jersey strategic we their seats found tests was state voiced and we've as capacity their us have Missouri, revenue testing We have who were doing mid-April, time, throughout XX may perform far would our restrictions. done more includes In last totals and a New Institute daily enough our to the last and should expect tracking nursing data remains have state's pandemic. are through the relationships really time. the who COVID-XX that be dedication, this remain I The testings and shareholders additional win every found as to would clear listening about well substantial vaccine me each coronavirus us per from what that they We long-term testing the walk day. secure the the State need that quarter. A Harvard testing. our state half safely not you regards and York At Columbia financials to the extremely commercial provide employees remarkable. accomplished testing from historic strategy proud with to thank will within just Massachusetts some
